StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen U.S. Plan — Notes Receivable from Participants by Year

U.S. Plan — Notes Receivable from Participants ($M) ($M)

Amgen U.S. Plan — Notes Receivable from Participants: $39.1M in FY2025, up 9.7% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
39.1
Period ended Dec 31, 2025
Change on a year earlier
+9.7%
35.6 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below

Where the FY2025 figure comes from

“|| Notes receivable from participants | 39,060,714 | 35,591,211”

Source: Form 11-K (Retirement & Savings Plan) (amgn-20260611.htm, filed 2026-06-11) ↗

Reported in Form 11-K Amgen Retirement and Savings Plan (U.S.).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Plan — Notes Receivable from Participants ($M) ($M)Year on yearSource
FY2025Dec 31, 202539.1+9.7%Form 11-K (Retirement & Savings Plan) (amgn-20260611.htm, filed 2026-06-11) ↗
FY2024Dec 31, 202435.6+13.9%Form 11-K (Retirement & Savings Plan) (a2024usplan11-k.htm, filed 2025-06-12) ↗
FY2023Dec 31, 202331.3+2.5%Form 11-K (Retirement & Savings Plan) (a2023usplan11-k.htm, filed 2024-06-21) ↗
FY2022Dec 31, 202230.5-0.5%Form 11-K (Retirement & Savings Plan) (a2022usplan11-k.htm, filed 2023-06-15) ↗
FY2021Dec 31, 202130.6-7.8%Form 11-K (Retirement & Savings Plan) (a2021usplan11-k.htm, filed 2022-06-24) ↗
FY2020Dec 31, 202033.2-7.1%Form 11-K (Retirement & Savings Plan) (a2020usplan11-k.htm, filed 2021-06-23) ↗
FY2019Dec 31, 201935.8-3.1%Form 11-K (Retirement & Savings Plan) (a2019usplan11-k.htm, filed 2020-06-17) ↗
FY2018Dec 31, 201836.9+0.2%Form 11-K (Retirement & Savings Plan) (a2018usplan11-k.htm, filed 2019-06-18) ↗
FY2017Dec 31, 201736.8–Form 11-K (Retirement & Savings Plan) (a2018usplan11-k.htm, filed 2019-06-18) ↗

Cite this data

StockData. (2026). Amgen U.S. Plan — Notes Receivable from Participants ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan-us-loans

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.